Why has there been a global surge of new Covid variant NB.1.8.1?
India is the latest country to report a surge in new Covid cases, as the latest variant NB.1.8.1 spreads across the globe.
Cases have now been reported in Asian countries such as Thailand, Indonesia and China, while the UKHSA recorded the first 13 cases in England last week.
However, the true numbers are unlikely to be known, given the significant decrease in the number of people testing compared to the figures seen during the global pandemic five years ago.
What do we know about the variant NB.1.8.1?
NB.1.8.1 stemmed from the Omicron variant and was first detected in January this year.
It has quickly spread across China and Hong Kong, and has now been recorded in several states across the United States and Australia.
By late April, NB.1.8.1 comprised about 10.7 per cent of submitted sequences globally, according to the World Health Organization (WHO). This rose from just 2.5 per cent one month before.
The WHO declared the NB.1.8.1 strain a 'variant under monitoring' on 23 May, which means scientists believe it could potentially affect the behaviour of the virus.
Why has there been a surge in new cases?
Lara Herrero, a virologist from Griffith University in Australia, suspects that NB.1.8.1 spreads more easily than other variants.
'Using lab-based models, researchers found NB.1.8.1 had the strongest binding affinity to the human ACE2 receptor of several variants tested, suggesting it may infect cells more efficiently than earlier strains,' Dr Herrero wrote last month in The Conversation.
Dr Chun Tang, GP at Pall Mall Medical, added: 'NB.1.8.1 isn't too different from the Omicron variant, but it does have some tweaks to its spike protein, which might make it spread a bit more easily or slip past some of our existing immunity.
'That said, early signs suggest it doesn't seem to cause more serious illness, but of course, we're still learning more about it.'
'Its spread has been identified in around 22 countries,' said Dr Naveed Asif, GP at The London General Practice.
'The WHO assesses the additional risk to the global public as currently low, and existing Covid-19 vaccines are considered effective in preventing severe disease.'
However, Nimbus does appear to be more transmissible than previous variants, with notable increases reported in India, Hong Kong, Singapore, and Thailand, notes Dr Asif.
What are the symptoms?
Common symptoms of the NB.1.8.1 variant include a severe sore throat. fatigue, mild cough, fever, muscle aches and congestion.
It has also been reported that some patients have experienced gastrointestinal symptoms such as nausea and diarrhoea.
Healthcare experts have stressed, however, that there is no evidence that the new strain is more deadly or serious than previous variants, and that current Covid vaccines are expected to remain effective and protect anyone infected from severe illness.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
20 minutes ago
- Daily Mail
GP issues warning over new Covid symptom amid fears Nimbus variant will sweep the UK this summer
Doctors are urging anyone with a 'razor blade' throat that they could have a new and highly contagious Covid variant. Dubbed 'Nimbus', the strain is descended from the super virulent Omicron, with 13 cases having already been found in the UK, following a surge in cases in China, Singapore and Hong Kong. Whilst experts say Nimbus symptoms are broadly similar to earlier versions of the virus a 'razor blade sore throat' could be a key sign of the new variant. According to Dr Naveed Asif, a GP at The London General Practice, this distinctive symptom is characterised by a sharp, stabbing pain when swallowing, often at the back of the throat. Other symptoms linked to the strain include redness in the back of the mouth and swollen neck glands as well established common Covid symptoms like fever, muscle aches and congestion. 'However, symptoms can vary widely so vigilance is key', Dr Asif told Manchester Evening News. According to the NHS, Covid symptoms include a high temperature, a new continuous cough, a loss or change to sense of smell or taste, shortness of breath and feeling sick. Whilst only 13 British cases of Nimbus have been identified so, these figures likely underestimate how far the variant has spread. This is because the number of Covid tests carried out has massively decreased since the height of pandemic and lockdown. Data from the UK Health Security Agency (UKHSA) shows the number of people testing positive for Covid has hit record levels this year and is already 97 per cent higher than numbers recorded in March. Experts have also warned that the new strain could lead to a surge in Covid cases over the summer and have urged the vulnerable to get vaccinated. Even those who were previously vaccinated or infected could be at risk of the catching the virus as previously built-up immunity fades over time. Professor Lawrence Young, a virologist at Warwick University, put the potential surge in cases down to warmer weather and busier social lives. 'We are very likely to see a spike of infections over the next couple of months, possibly by later this month or in July. But it's difficult to predict the level of this infection wave,' he told The i Paper. 'Population immunity, either from vaccination or previous infection, is waning and, unlike other respiratory viruses such as flu, the Covid virus continues to spread in hot and humid weather,' he said. Lab studies suggest Nimbus can infect human cells more efficiently than previous strains, making it more likely to infect people. However, there is currently no evidence Nimbus is more likely to cause severe illness or death in those it infects compared to previous variants. But infection with the virus can still be deadly for more vulnerable groups. Covid was a factor in the deaths of just over 300 people in England in May, according to the latest official figures. Experts have also said that current Covid vaccines, which have been reformulated to combat Omicron descendants, are expected to remain effective against Nimbus. According to the World Health Organisation, Nimbus, scientifically known as NB.1.8.1, now accounts for 10.7 per cent of Covid infections worldwide, compared to just 2.5 per cent a month prior. Dr Gayatri Amirthalingam, UKHSA's deputy director, said the organisation was keeping a close eye on Nimbus. 'UKHSA is monitoring all available data relating to SARS-CoV-2 variants in the UK and abroad, and we continue to publish our findings in our regular Flu and Covid-19 surveillance reports,' she said. 'NB.1.8.1 has been detected in small numbers in the UK to date, but international data suggests that it is growing as a proportion of all Covid-19 cases.' Currently adults over the age of 75, care home residents, and those aged six months and over who have weakened immune systems are all eligible for a free Covid vaccine across the UK. This includes organ, bone marrow or stem cell transplant patients, people living with HIV, cancer patients undergoing chemotherapy or radiotherapy and those with genetic disorders affecting the immune system. UKHSA data suggests people who had a Covid jab as part of last spring's booster campaign were 45 per cent less likely to need hospital care for the virus in the weeks that followed compared to the unvaccinated. The agency has urged all people eligible for a vaccine to get jabbed to protect themselves from both NB.1.8.1 and Covid in general.
The Guardian
39 minutes ago
- The Guardian
India to send first astronaut on mission to International Space Station
The first Indian astronaut to visit the International Space Station is due to blast off as part of an effort by the world's most populous nation to catch up with the US, Russia and China in human space flight missions. Shubhanshu Shukla, a 39-year-old air force fighter pilot, is one of a four-person mission launching on Tuesday from the US with the private company Axiom Space, which is using a SpaceX capsule. He will be the first Indian astronaut to reach orbit in more than four decades after Rakesh Sharma's 1984 flight aboard a Soviet Soyuz spacecraft. 'I truly believe that even though, as an individual, I am travelling to space, this is the journey of 1.4 billion people,' Shukla was quoted as saying by the Hindu newspaper this year. Shukla said he hoped to 'ignite the curiosity of an entire generation in my country'. India's department of space has called the trip a 'defining chapter' in its ambitious space exploration programme. The International Space Station mission (ISS) 'stands as a symbol of a confident, forward-looking nation ready to reclaim its place in the global space race', the agency said before the launch. 'His journey is more than just a flight – it's a signal that India is stepping boldly into a new era of space exploration.' New Delhi has paid more than $60m for the mission, according to Indian media reports. The prime minister, Narendra Modi, has announced plans to send a person to the moon by 2040. The Indian Space Research Organisation, meanwhile, is planning to launch its own human spaceflight mission, called Gaganyaan, or 'sky craft' in Hindi, in 2027. Shukla is a contender to be part of that trip. Shukla trained at the Yuri Gagarin Cosmonaut Training Center in Russia in 2020, before undertaking further training at the ISRO's centre in Bengaluru. He has said the journey aboard the Axiom Mission 4, and the expected 14 days on the ISS, will provide 'invaluable' lessons to bring back home. Shukla will be led by the mission commander, Peggy Whitson, a former Nasa astronaut and an Axiom employee, and joined by the European Space Agency astronaut Sławosz Uznański-Wiśniewski, of Poland, and Tibor Kapu, of Hungary. They will conduct 60 scientific studies, including microgravity research, earth observation, and life, biological and material sciences experiments. India's space programme has grown considerably in size and momentum in the last decade, matching the achievements of established powers at a much cheaper price. In August 2023, it became the fourth nation to land an unmanned craft on the moon after Russia, the US and China. Agence France-Presse contributed to this report
Scotsman
an hour ago
- Scotsman
signs and symptoms to look out for
This article contains affiliate links. We may earn a small commission on items purchased through this article, but that does not affect our editorial judgement. Cases of Covid have increased by 10.1% 🤧 Sign up to our daily newsletter Sign up Thank you for signing up! Did you know with a Digital Subscription to Edinburgh News, you can get unlimited access to the website including our premium content, as well as benefiting from fewer ads, loyalty rewards and much more. Learn More Sorry, there seem to be some issues. Please try again later. Submitting... 13 cases of a new Covid strain have been detected in the UK. NB.1.8.1 was first detected in January 2025 and originates from the Omicron variant. The World Health Organisation (WHO) have confirmed it is a variant under monitoring (VUM). Cases of Covid have increased 10.1% according to latest figures from UK Health and Security Agency (UKHSA). Cases of a new Covid variant have been detected in the UK. NB.1.8.1 has already caused a spike in infections and hospitalisations in China and has been identified in 22 countries, with the WHO confirming they have classed it is a 'variant under monitoring'. There have been many different types of variants and subvariants of Covid since the pandemic. NB.1.8.1 is the latest on the scene after the emergence of LP.8.1., which is the most dominant variant in the UK. Advertisement Hide Ad Advertisement Hide Ad Covid infections have been on the rise in the UK, with latest data from UKHSA which revealed up to the week of May 28, cases had increased by 10.1%, up 103 to 1,124. Here's everything you need to know about how many cases of the new variant are in the UK and what symptoms to look out for. There have been 13 cases recorded of the new Covid variant in the UK. | Pexels What is the new Covid strain NB.1.8.1? First detected on January 22, 2025, the new Covid strain, NB.1.8.1 originates from the omicron variant which saw cases spike in 2023. Despite an increase in cases and hospitalisations in some countries where NB.1.8.1 is widespread, the WHO have revealed that current data does not indicate that it leads to more severe illness than current variants. Advertisement Hide Ad Advertisement Hide Ad WHO have designated it as a 'variant under monitoring', but the overall risk to public health has been posed to be 'low', with current Covid vaccines expected to be effective in protecting vulnerable patients from severe illness. How many cases of new Covid variant have been found in the UK? The UKHSA confirmed that there have been 13 cases of NB.1.8.1 found in the UK. Cases of Covid, in the week up to May 28, had increased by 10.1%, up 103 to 1,124, whilst deaths also increased by 5.9% and hospitalisations were up 3.5%. Advertisement Hide Ad Advertisement Hide Ad What are the symptoms of the new Covid variant in the UK? Despite the many different variants, the symptoms of Covid have remained the same. The NHS explain Covid symptoms can include: a high temperature or shivering (chills) a new, continuous cough a loss or change to your sense of smell or taste shortness of breath feeling tired or exhausted an aching body a headache a sore throat a blocked or runny nose loss of appetite diarrhoea feeling sick or being sick Symptoms of Covid are very similar to symptoms of other illnesses, such as colds and flu, which is why if you suspect you have Covid it's important to take a test to confirm or rule out the infection. Most people who have Covid tend to feel better after a few weeks, but it can take longer to recover, with some people experiencing a more serious reaction and prolonged symptoms. 🧪 Boots COVID-19 Test Kits While free testing is no longer widely available, Boots continues to offer a range of COVID-19 lateral flow kits for home use, with results in under 30 minutes. Advertisement Hide Ad Advertisement Hide Ad They're available individually or in multipacks, with options for general use, travel, or workplace settings. If you have a health story to share with us, we'd love to hear from you. You can now send your stories to us online via YourWorld at It's free to use and, once checked, your story will appear on our website and, space allowing, in our newspapers.
